GlobeNewswire
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
📈
AI Sentiment
Highly Positive
8/10
- Home
- DRTS
as of 12-05-2025 3:29pm EST
$3.90
$0.16
-3.94%
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Chart Type:
Time Range:
| Founded: | 2015 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 300.2M | IPO Year: | N/A |
| Target Price: | $9.00 | AVG Volume (30 days): | 62.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.30 - $4.69 | Next Earning Date: | 11-20-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered DRTS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 79.25%
79.25%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Alpha Tau Medical Ltd. News
DRTS Breaking Stock News: Dive into DRTS Ticker-Specific Updates for Smart Investing
GlobeNewswire
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Alpha Tau to Participate in December Investor Conferences
📊
AI Sentiment
Positive
7/10
Compare DRTS vs Leading Stocks
See how DRTS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DRTS Alpha Tau Medical Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.